Financial statements Friends Pharm
Balance sheet data of FRIENDS PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 659 146,26 | 3 369 114,88 | 3 652 130,61 | 3 612 269,57 | 3 776 968,07 | 3 855 194,65 |
| A. Fixed assets | 96 964,02 | 85 589,99 | 159 554,30 | 113 010,15 | 22 552,13 | 0,00 |
| B. Current assets | 3 562 182,24 | 3 283 524,89 | 3 492 576,31 | 3 499 259,42 | 3 754 415,94 | 3 855 194,65 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 3 659 146,26 | 3 369 114,88 | 3 652 130,61 | 3 612 269,57 | 3 776 968,07 | 3 855 194,65 |
| A. Equity | 1 365 574,98 | 1 535 803,00 | 1 401 431,96 | 1 638 567,36 | 2 426 410,45 | 1 674 623,94 |
| B. Liabilities and provisions for liabilities | 2 293 571,28 | 1 833 311,88 | 2 250 698,65 | 1 973 702,21 | 1 350 557,62 | 2 180 570,71 |
| I. Long-term liabilities | 0,00 | - | - | 88 254,44 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 293 571,28 | 1 833 311,88 | 2 250 698,65 | 1 885 447,77 | 1 350 557,62 | 2 180 570,71 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.